Tidal Therapeutics Overview

  • Founded
  • 2019

Founded
  • Status
  • Acquired/​Merged

  • Employees
  • 9

Employees
  • Latest Deal Type
  • M&A

  • Latest Deal Amount
  • $470M

Tidal Therapeutics General Information

Description

Operator of a preclinical-stage company intended to utilize a novel mRNA-based approach to in vivo reprogramming of immune cells. The company is focused on developing nanoparticles that deliver mRNA to reprogram immune cells inside the body with applications in oncology and immune diseases, thus providing the healthcare industry with pre-clinical programs for cancer indications.

Contact Information

Ownership Status
Acquired/Merged
(Operating Subsidiary)
Financing Status
Formerly VC-backed
Primary Industry
Drug Discovery
Other Industries
Other Healthcare Technology Systems
Biotechnology
Parent Company
Primary Office
  • 49 Sycamore Road
  • Quincy, MA 02171
  • United States

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Tidal Therapeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Merger/Acquisition 09-Apr-2021 $470M 00000 Completed Generating Revenue
2. Early Stage VC 01-Jan-2020 Completed Startup
1. Seed Round 01-Jul-2019 Completed Startup
To view Tidal Therapeutics’s complete valuation and funding history, request access »

Tidal Therapeutics Executive Team (2)

Name Title Board Seat Contact Info
Matthias Stephan Scientific Co-Founder
Ulrik Nielsen Ph.D Co-Founder, Chief Executive Officer, President and Board Member
To view Tidal Therapeutics’s complete executive team members history, request access »

Tidal Therapeutics Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Tidal Therapeutics Former Investors (4)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
MRL Ventures Fund Corporate Venture Capital Minority 000 0000 000000 0
Mission BioCapital Venture Capital Minority 000 0000 000000 0
Myeloma Investment Fund Corporate Venture Capital Minority 000 0000 000000 0
New Enterprise Associates Venture Capital Minority 000 0000 000000 0
To view Tidal Therapeutics’s complete investors history, request access »